In addition, Rodriguez-Mora et al. [52] indicated that CaMK inhibitor could increase the treatment efficacy of doxorubicin, ionizing radiation, or photodynamic therapy in breast cancer cells. This evidence concerns the gene CAMK2G and breast carcinoma.